JP2006515561A5 - - Google Patents

Download PDF

Info

Publication number
JP2006515561A5
JP2006515561A5 JP2004514955A JP2004514955A JP2006515561A5 JP 2006515561 A5 JP2006515561 A5 JP 2006515561A5 JP 2004514955 A JP2004514955 A JP 2004514955A JP 2004514955 A JP2004514955 A JP 2004514955A JP 2006515561 A5 JP2006515561 A5 JP 2006515561A5
Authority
JP
Japan
Prior art keywords
antibody
apo
sample
detecting
produced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004514955A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006515561A (ja
Filing date
Publication date
Priority claimed from FR0207542A external-priority patent/FR2841249A1/fr
Application filed filed Critical
Publication of JP2006515561A publication Critical patent/JP2006515561A/ja
Publication of JP2006515561A5 publication Critical patent/JP2006515561A5/ja
Pending legal-status Critical Current

Links

JP2004514955A 2002-06-19 2003-06-19 Apo−B48及びApo−B100のアッセイのための組成物及び方法 Pending JP2006515561A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0207542A FR2841249A1 (fr) 2002-06-19 2002-06-19 Compositions et methodes pour le dosage de l'apo b48 et de l'apo b100
PCT/FR2003/001888 WO2004000884A2 (fr) 2002-06-19 2003-06-19 Compositions et methodes pour le dosage de l'apo b48 et de l'apo b100

Publications (2)

Publication Number Publication Date
JP2006515561A JP2006515561A (ja) 2006-06-01
JP2006515561A5 true JP2006515561A5 (enExample) 2006-08-17

Family

ID=29719858

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004514955A Pending JP2006515561A (ja) 2002-06-19 2003-06-19 Apo−B48及びApo−B100のアッセイのための組成物及び方法

Country Status (11)

Country Link
US (1) US20050152900A1 (enExample)
EP (1) EP1513878B1 (enExample)
JP (1) JP2006515561A (enExample)
AT (1) ATE356832T1 (enExample)
AU (1) AU2003267493A1 (enExample)
CA (1) CA2489057A1 (enExample)
DE (1) DE60312513T2 (enExample)
DK (1) DK1513878T3 (enExample)
ES (1) ES2283803T3 (enExample)
FR (1) FR2841249A1 (enExample)
WO (1) WO2004000884A2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2005093415A1 (ja) * 2004-03-29 2008-02-14 株式会社シバヤギ アポリポタンパク質b−48の測定方法およびその用途
WO2007058588A1 (en) * 2005-11-18 2007-05-24 T.A.C Thrombosis And Coagulation Aktiebolag Monoclonal antibodies against apolipoprotein m
JP2009531712A (ja) * 2006-03-23 2009-09-03 デ グスマン ブレイヤー、エメリタ アポリポタンパク質フィンガープリント技術
US8088593B2 (en) 2007-10-02 2012-01-03 Theranos, Inc. Modular point-of-care devices, systems, and uses thereof
JP5832723B2 (ja) * 2009-03-06 2015-12-16 協和メデックス株式会社 可溶性インターロイキン−2受容体定量用標準品
EP2408812B1 (en) * 2009-03-17 2015-12-16 CardioVax, LLC Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis and related proteins, peptides and compositions
WO2011060329A1 (en) 2009-11-14 2011-05-19 Kuang-Yuh Chyu Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis
US8506964B2 (en) 2010-02-05 2013-08-13 Cardiovax, Llc Fusion proteins and related compositions, methods and systems for treatment and/or prevention of atherosclerosis
RU2013126628A (ru) 2010-11-12 2014-12-20 Седарс-Синаи Медикал Сентер Иммуномодулирующие способы и системы для лечения и/или предотвращения аневризм
CA2817543A1 (en) 2010-11-12 2012-06-07 Cedars-Sinai Medical Center Immunomodulatory methods and systems for treatment and/or prevention of hypertension
CN106323875B (zh) 2011-01-21 2019-07-09 西拉诺斯知识产权有限责任公司 样品使用最大化的系统和方法
US20140170735A1 (en) 2011-09-25 2014-06-19 Elizabeth A. Holmes Systems and methods for multi-analysis
US8475739B2 (en) 2011-09-25 2013-07-02 Theranos, Inc. Systems and methods for fluid handling
US9268915B2 (en) 2011-09-25 2016-02-23 Theranos, Inc. Systems and methods for diagnosis or treatment
US9664702B2 (en) 2011-09-25 2017-05-30 Theranos, Inc. Fluid handling apparatus and configurations
US9632102B2 (en) 2011-09-25 2017-04-25 Theranos, Inc. Systems and methods for multi-purpose analysis
US10012664B2 (en) 2011-09-25 2018-07-03 Theranos Ip Company, Llc Systems and methods for fluid and component handling
US9810704B2 (en) 2013-02-18 2017-11-07 Theranos, Inc. Systems and methods for multi-analysis
US9250229B2 (en) 2011-09-25 2016-02-02 Theranos, Inc. Systems and methods for multi-analysis
US11008628B1 (en) 2013-02-18 2021-05-18 Labrador Diagnostics Llc Systems and methods for analyte testing and laboratory oversight
US10401373B1 (en) 2013-02-18 2019-09-03 Theranos Ip Company, Llc Systems and methods for analyte testing and laboratory oversight
US10422806B1 (en) 2013-07-25 2019-09-24 Theranos Ip Company, Llc Methods for improving assays of biological samples
US11360107B1 (en) 2014-02-25 2022-06-14 Labrador Diagnostics Llc Systems and methods for sample handling
CN106053793A (zh) * 2016-06-20 2016-10-26 诺莱生物医学研究院(北京)有限公司 一种快速检测乳糜血的免疫层析试纸卡及其制备方法
WO2025111449A1 (en) * 2023-11-21 2025-05-30 Sun Diagnostics, Inc. Method and reagent to clear turbidity due to elevated triglycerides in a biological specimen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60193926A (ja) * 1984-03-15 1985-10-02 Tokyo Daigaku 単クローン性抗ヒトアポリポ蛋白質b100抗体
JPS617299A (ja) * 1984-06-20 1986-01-13 Dai Ichi Pure Chem Co Ltd ヒトアポリポ蛋白b48に高い特異性を有する単クローン性抗体
US6635623B1 (en) * 1997-06-13 2003-10-21 Baylor College Of Medicine Lipoproteins as nucleic acid vectors

Similar Documents

Publication Publication Date Title
KR101669918B1 (ko) 사람 체액 중의 시스타틴 c의 측정방법
EP3056517B1 (en) Monoclonal antibody and immunoassay using the same
JP2006515561A (ja) Apo−B48及びApo−B100のアッセイのための組成物及び方法
JP4012722B2 (ja) カルボキシメチル化ペプチドに対する抗体
WO2011010673A1 (ja) インスリン測定方法
WO2008059837A1 (en) Antibody against aflatoxins, support using the antibody, method of immunologically detecting aflatoxins and method of concentrating and purifying aflatoxins
JP4413179B2 (ja) 免疫学的粒子凝集反応方法
US11067579B2 (en) Target marker GP73 for detecting steatohepatitis and detection application method
CN101466732A (zh) Iv型胶原样免疫反应性多肽
US20190169313A1 (en) Monoclonal antibody specific for gamma-glutamyl-l-epsilon-lysine for the monitoring of apoptosis
JP3998245B2 (ja) 酸化アポリポタンパク質ai及びそれを含有する酸化リポタンパク質の測定法及びキット
JP5322638B2 (ja) チトクロムcを測定することによる肺傷害検査方法および検査キット
CN106932593B (zh) 以ncam‑1为检测指标的双抗体夹心酶联免疫吸附检测试剂盒及其应用
JP3713585B2 (ja) 変性又は修飾リポタンパク質(a)に結合する抗体及びこの抗体を用いる測定法
JP4588053B2 (ja) 酸化アポリポタンパク質ai及びそれを含有する酸化リポタンパク質の測定法及びキット
JP3433245B2 (ja) ビタミンb12を決定するためのイムノアッセイ、ならびにそのための試薬およびキット
Choi et al. Detection of β-amyloid (1-42) on protein array based on electrical detection technique using scanning tunneling microscopy
JP4192092B2 (ja) アルコール消費量を検出するための方法および手段
JP4422291B2 (ja) ヒトメダラシンの免疫学的測定方法
JP4196376B2 (ja) フルクトシルアミノ酸標識物を用いたHbA1cの免疫的測定方法
JPWO2005082940A1 (ja) 抗nc1モノクローナル抗体
JP4363767B2 (ja) 多発性硬化症の検査方法
JP3542245B2 (ja) 糖尿病もしくは糖尿病合併症用マーカーとしての使用および免疫試薬
WO2021107105A1 (ja) 免疫反応を利用したアナライトの測定方法及び測定試薬
JP2004184125A (ja) 免疫学的検出試薬、該試薬を用いた検出方法及び該試薬の製造方法